Position in ABBV
as of Jun 30, 2026
· filed Jul 13, 2026
Position Value
$7,106,816
+$1,172,602 QoQ
Shares Held
28,242
+3.5% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
4.08%
of 13F equity value
Holder Rank
#1,101
of 4,153 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Southland Equity Partners LLC holds $15,588,502 across 9 Drug Manufacturers - General names. ABBV ranks #1 (45.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
This page
|
28,242 | $7,106,816 | |
| 2 | JNJ |
Johnson & Johnson
|
20,549 | $5,218,829 | |
| 3 | LLY |
ELI LILLY & Co
|
693 | $831,205 | |
| 4 | NVS |
Novartis AG
|
3,807 | $596,633 | |
| 5 | AMGN |
Amgen Inc
|
1,418 | $513,486 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
3,452 | $436,125 | |
| 7 | NVO |
Novo Nordisk A S
|
7,811 | $374,459 | |
| 8 | MRK |
Merck & Co., Inc.
|
2,154 | $276,789 |
All Filings in ABBV
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $7,106,816 | 28,242 | Shares | Sole | 2026-07-13 | |
| 2026-03-31 | $5,934,214 | 27,285 | Shares | Sole | 2026-04-14 | |
| 2025-12-31 | $6,296,727 | 27,558 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $6,553,508 | 28,304 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $5,231,328 | 28,183 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $5,938,634 | 28,344 | Shares | Sole | 2025-04-16 | |
| 2024-12-31 | $5,054,676 | 28,445 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $4,836,482 | 24,491 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,045,337 | 17,755 | Shares | Sole | 2024-07-12 | |
| 2024-03-31 | $1,397,981 | 7,677 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $960,194 | 6,196 | Shares | Sole | 2024-01-09 | |
| 2023-09-30 | $970,529 | 6,511 | Shares | Sole | 2024-01-02 | |
| 2023-06-30 | $858,769 | 6,374 | Shares | Sole | 2024-01-02 | |
| 2023-03-31 | $718,758 | 4,510 | Shares | Sole | 2024-01-02 | |
| 2022-12-31 | $735,810 | 4,553 | Shares | Sole | 2024-01-02 | |
| 2022-09-30 | $548,784 | 4,089 | Shares | Sole | 2024-01-02 | |
| 2022-06-30 | $655,065 | 4,277 | Shares | Sole | 2024-01-02 | |
| 2022-03-31 | $681,834 | 4,206 | Shares | Sole | 2024-01-02 | |
| 2021-12-31 | $568,815 | 4,201 | Shares | Sole | 2024-01-02 | |
| 2021-09-30 | $443,237 | 4,109 | Shares | Sole | 2024-01-02 | |
| 2021-06-30 | $445,603 | 3,956 | Shares | Sole | 2024-01-02 | |
| 2021-03-31 | $427,577 | 3,951 | Shares | Sole | 2024-01-02 | |
| 2020-12-31 | $404,491 | 3,775 | Shares | Sole | 2024-01-02 | |
| No filing history on record for this holder in this stock. | ||||||